Skip to Main Content

Paper Details

Event-Free Survival, a Prostate-Specific Antigen-Based Composite End Point, Is Not a Surrogate for Overall Survival in Men With Localized Prostate Cancer Treated With Radiation.
J Clin Oncol
35
2020
Cancer of the Prostate, Localized Prostate Cancer, Men, PSA, Prostate-Specific Antigen, copula, localized prostate cancer, men, patient, patients, prostate cancer, prostate-specific antigen
Author NameAffiliation
Meredith M ReganDana-Farber Cancer Institute
Philip W KantoffMemorial Sloan-Kettering Cancer Center
Philip W KantoffMemorial Sloan-Kettering Cancer Center
Oliver SartorTulane University
Donald A BerryThe University of Texas MD Anderson Cancer Center
Laurence Collette
Anthony V D'AmicoBrigham and Women's Hospital and Dana-Farber Cancer Institute
Mario A EisenbergerSidney Kimmel Comprehensive Cancer Center, Johns Hopkins University
Nicolas MottetUniversity Jean Monnet
Howard M SandlerCedars Sinai Medical Center
Daniel E SprattUniversity of Michigan ann arbor
  • 1 - 11

Datasets

Release 1.2